BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34414683)

  • 1. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.
    Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Ichikawa Y; Kobayashi A; Shibahara T; Yanagawa Y; Higuchi H; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immun Inflamm Dis; 2021 Dec; 9(4):1573-1583. PubMed ID: 34414683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis.
    Goto S; Konnai S; Okagawa T; Nishimori A; Maekawa N; Gondaira S; Higuchi H; Koiwa M; Tajima M; Kohara J; Ogasawara S; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immun Inflamm Dis; 2017 Sep; 5(3):355-363. PubMed ID: 28544524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in sheep.
    Tiyamanee W; Konnai S; Okagawa T; Nojima Y; Ganbaatar O; Maekawa N; Hasebe R; Kagawa Y; Kato Y; Suzuki Y; Murata S; Ohashi K
    Vet Immunol Immunopathol; 2023 Jul; 261():110609. PubMed ID: 37201379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.
    Watari K; Konnai S; Okagawa T; Maekawa N; Sajiki Y; Kato Y; Suzuki Y; Murata S; Ohashi K
    J Vet Med Sci; 2022 Jan; 84(1):6-15. PubMed ID: 34789592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade.
    Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Minato E; Kobayashi A; Ando R; Sasaki N; Miyakoshi D; Ichii O; Kato Y; Suzuki Y; Murata S; Ohashi K
    PLoS One; 2020; 15(11):e0234218. PubMed ID: 33216754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
    Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
    Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade.
    Ikebuchi R; Konnai S; Shirai T; Sunden Y; Murata S; Onuma M; Ohashi K
    Vet Res; 2011 Sep; 42(1):103. PubMed ID: 21943148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.
    Suleman M; Cyprian FS; Jimbo S; Maina T; Prysliak T; Windeyer C; Perez-Casal J
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311234
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostaglandin E
    Sajiki Y; Konnai S; Okagawa T; Nishimori A; Maekawa N; Goto S; Ikebuchi R; Nagata R; Kawaji S; Kagawa Y; Yamada S; Kato Y; Nakajima C; Suzuki Y; Murata S; Mori Y; Ohashi K
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29483289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes.
    Ikebuchi R; Konnai S; Okagawa T; Yokoyama K; Nakajima C; Suzuki Y; Murata S; Ohashi K
    Immunology; 2014 Aug; 142(4):551-61. PubMed ID: 24405267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokaryotic expression of the extracellular domain of porcine programmed death 1 (PD-1) and its ligand PD-L1 and identification of the binding with peripheral blood mononuclear cells
    Zhu YP; Yue F; He Y; Li P; Yang Y; Han YT; Zhang YF; Sun GP; Guo DG; Yin M; Wang XN
    Can J Vet Res; 2017 Apr; 81(2):147-154. PubMed ID: 28408783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models.
    Kurino T; Matsuda R; Terui A; Suzuki H; Kokubo T; Uehara T; Arano Y; Hisaka A; Hatakeyama H
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32041818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression.
    Sajiki Y; Konnai S; Ikenaka Y; Gulay KCM; Kobayashi A; Parizi LF; João BC; Watari K; Fujisawa S; Okagawa T; Maekawa N; Logullo C; da Silva Vaz I; Murata S; Ohashi K
    Sci Rep; 2021 Jan; 11(1):1063. PubMed ID: 33441793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 blockade inhibits lymphocyte apoptosis and restores proliferation and anti-viral immune functions of lymphocyte after CP and NCP BVDV infection in vitro.
    Liu Y; Liu S; He B; Wang T; Zhao S; Wu C; Yue S; Zhang S; He M; Wang L; Huang W; Shi T; Zhu Z
    Vet Microbiol; 2018 Nov; 226():74-80. PubMed ID: 30389046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection.
    Zhang E; Zhang X; Liu J; Wang B; Tian Y; Kosinska AD; Ma Z; Xu Y; Dittmer U; Roggendorf M; Yang D; Lu M
    PLoS One; 2011; 6(10):e26196. PubMed ID: 22022563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.